Researchers at the Bloomberg-Kimmel Institute for Cancer Immunotherapy in the Johns Hopkins Kimmel Cancer Center discovered inhibiting a previously known protein could reduce tumor burdens and enhance the effectiveness of immunotherapy treatments.
All news from Anaesthesiology
Eating high fiber foods may reduce the effects of stress on our gut and behavior, according to new research published in The Journal of Physiology. Stress is a significant health concern and can cause major changes in the gut and in the brain, which can cause changes in behavior.
A stint in a sauna is not only pleasant and relaxing but may also improve health, according to the authors of a new, comprehensive literature review. Among the benefits they identified were a reduced risk for cardiovascular, neurocognitive, and pulmonary illnesses such as asthma and influenza
The US Food and Drug Administration (FDA) is cracking down on manufacturers marketing the use of laser or other energy-based devices for "vaginal rejuvenation" which manufacturers claim will treat conditions and symptoms related to menopause, urinary incontinence, or sexual function.
The U.S. Food and Drug Administration (FDA) has approved the first ever non-surgical treatment for the rare neuroendocrine cancers pheochromocytoma and paraganglioma.
Healthcare teams in patient care settings can develop policies and procedures to minimize the impact of drug shortages by incorporating new guidelines published today by ASHP (American Society of Health-System Pharmacists).
Although cancer screening rates have been increasing in the United States, they are still below national targets, says the Centers for Disease Control and Prevention (CDC).
Omeros Corporation announced that the European Medicines Agency's (EMA's) Committee for Orphan Medicinal Products (COMP) issued a positive opinion recommending orphan drug designation of OMS721 for treatment in hematopoietic stem cell transplantation.
Ivosidenib, an oral, targeted inhibitor of the IDH1 enzyme, is the first and only FDA-approved therapy for patients with R/R AML and an IDH1 mutation. Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the U.S. Food and Drug Administration
Researchers have identified a previously unknown feature of human anatomy that has implications for the function of all organs, most tissue, and the mechanisms of many major diseases. People have been studying the human body for hundreds of years and you might think we know all there is to know about human anatomy today. The study was published in the Scientific Reports.